← FDA Drug Approvals (Drugs@FDA)
NEOSTIGMINE METHYLSULFATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: REGCON HOLDINGS · Approved 2021-10-01
Drug application
- FDA Application #
ANDA210652- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NEOSTIGMINE METHYLSULFATE
- Generic name
- NEOSTIGMINE METHYLSULFATE
- Active ingredients
- NEOSTIGMINE METHYLSULFATE
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- REGCON HOLDINGS
- Manufacturer
- Indoco Remedies Limited
- First approval
- 2021-10-01
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown